DK3038596T3 - Sammensætninger og fremgangsmåder til fjernelse af tatoveringer - Google Patents

Sammensætninger og fremgangsmåder til fjernelse af tatoveringer Download PDF

Info

Publication number
DK3038596T3
DK3038596T3 DK14838935.6T DK14838935T DK3038596T3 DK 3038596 T3 DK3038596 T3 DK 3038596T3 DK 14838935 T DK14838935 T DK 14838935T DK 3038596 T3 DK3038596 T3 DK 3038596T3
Authority
DK
Denmark
Prior art keywords
tattoo
procedures
compositions
removal
Prior art date
Application number
DK14838935.6T
Other languages
English (en)
Inventor
Alec Guy Falkenham
Original Assignee
Univ Dalhousie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Dalhousie filed Critical Univ Dalhousie
Application granted granted Critical
Publication of DK3038596T3 publication Critical patent/DK3038596T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/14—Preparations for removing make-up
    • A61Q1/145—Tattoo removal
DK14838935.6T 2013-08-30 2014-08-28 Sammensætninger og fremgangsmåder til fjernelse af tatoveringer DK3038596T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361871929P 2013-08-30 2013-08-30
PCT/CA2014/000663 WO2015027328A1 (en) 2013-08-30 2014-08-28 Compositions and methods for the removal of tattoos

Publications (1)

Publication Number Publication Date
DK3038596T3 true DK3038596T3 (da) 2020-04-06

Family

ID=52585331

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14838935.6T DK3038596T3 (da) 2013-08-30 2014-08-28 Sammensætninger og fremgangsmåder til fjernelse af tatoveringer

Country Status (9)

Country Link
US (4) US9801799B2 (da)
EP (1) EP3038596B1 (da)
AU (1) AU2014311225B2 (da)
BR (1) BR112016004372B1 (da)
CA (1) CA2921762C (da)
DK (1) DK3038596T3 (da)
ES (1) ES2782360T3 (da)
PT (1) PT3038596T (da)
WO (1) WO2015027328A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3347000A4 (en) * 2015-09-11 2019-03-27 Phio Pharmaceuticals Corp. METHODS OF TREATING DISORDERS AND SKIN DISORDERS USING HAPTENES
EP3368140A4 (en) * 2015-10-30 2019-07-03 Dabney Patents, L.L.C. SYSTEM, APPARATUS AND METHOD FOR ESTABLISHING AND REMOVING TATTOO
EP3284505B1 (de) 2016-08-18 2019-03-27 nolax AG Verfahren zum entfernen von tätowierungen und verwendung eines microneedle-patches in einem verfahren zum entfernen von tätowierungen
RU2722455C1 (ru) * 2020-01-28 2020-06-01 Марина Леонидовна Тынянова Способ удаления татуировок у человека и композиция для его осуществления

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5540934A (en) 1994-06-22 1996-07-30 Touitou; Elka Compositions for applying active substances to or through the skin
GB9620504D0 (en) * 1996-10-02 1996-11-20 Boehringer Ingelheim Ltd Compositions
US20100146256A1 (en) 2000-01-06 2010-06-10 Super Talent Electronics Inc. Mixed-Mode ROM/RAM Booting Using an Integrated Flash Controller with NAND-Flash, RAM, and SD Interfaces
GB0118517D0 (en) 2001-07-30 2001-09-19 Mitsubishi Tokyo Pharm Inc Compound
EP1603476A4 (en) 2003-03-13 2010-01-13 3M Innovative Properties Co PROCESS FOR REMOVING TATTOO
US20050201959A1 (en) * 2004-03-11 2005-09-15 Vvii Newco 2003, Inc. Methods and compositions for altering skin coloration
CN1964715A (zh) * 2004-05-06 2007-05-16 默克公司 治疗狗的关节炎状况的方法
US8187621B2 (en) 2005-04-19 2012-05-29 Advanced Cardiovascular Systems, Inc. Methods and compositions for treating post-myocardial infarction damage
WO2006127962A2 (en) 2005-05-25 2006-11-30 Becton, Dickinson And Comapny Particulate formulations for intradermal delivery of biologically active agents
US20070081962A1 (en) 2005-10-06 2007-04-12 Amit Munshi Novel delivery of immune response modifiers for removal of chronic tattoos
US20070218116A1 (en) * 2006-03-14 2007-09-20 Schwendener Reto A Compositions and methods for the treatment of tumors and tumor metastases
US9278233B2 (en) 2008-12-04 2016-03-08 Biochemics, Inc. Methods and compositions for tattoo removal
WO2010143193A1 (en) 2009-06-11 2010-12-16 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Targeted liposomes comprising n-containing bisphosphonates and uses thereof
US8637569B2 (en) * 2009-10-22 2014-01-28 Api Genesis, Llc Methods of increasing solubility of poorly soluble compounds and methods of making and using formulations of such compounds
EP2363111A1 (en) * 2010-03-01 2011-09-07 Combino Pharm, S.L. Stable pharmaceutical composition comprising bisphosphonate
WO2011132826A1 (en) 2010-04-19 2011-10-27 Snu R&Db Foundation Transdermal drug delivery system and pharmaceutical composition for preventing or treating bone diseases
US20110311616A1 (en) * 2010-06-17 2011-12-22 Jeff Smith Targeting tumor associated macrophages using bisphosphonate-loaded particles
CA2819635A1 (en) * 2010-12-01 2012-06-07 Spinal Modulation, Inc. Directed delivery of agents to neural anatomy
JP5864615B2 (ja) * 2011-01-25 2016-02-17 ザ プロクター アンド ギャンブルカンパニー リポソーム及びそれを含むパーソナルケア組成物
US9993427B2 (en) * 2013-03-14 2018-06-12 Biorest Ltd. Liposome formulation and manufacture

Also Published As

Publication number Publication date
PT3038596T (pt) 2020-04-03
AU2014311225A1 (en) 2016-03-10
EP3038596A1 (en) 2016-07-06
AU2014311225B2 (en) 2019-12-19
NZ717166A (en) 2021-05-28
WO2015027328A1 (en) 2015-03-05
US20160279045A1 (en) 2016-09-29
ES2782360T3 (es) 2020-09-14
EP3038596B1 (en) 2020-01-08
CA2921762A1 (en) 2015-03-05
EP3038596A4 (en) 2017-02-08
US20170042781A1 (en) 2017-02-16
BR112016004372B1 (pt) 2021-01-05
US20220257489A1 (en) 2022-08-18
US10105302B2 (en) 2018-10-23
US11344490B2 (en) 2022-05-31
US9801799B2 (en) 2017-10-31
CA2921762C (en) 2022-07-12
US20190008744A1 (en) 2019-01-10

Similar Documents

Publication Publication Date Title
DK3008168T3 (da) Sc-celler og sammensætninger og fremgangsmåde til dannelse deraf
DK3035926T3 (da) Forbindelser og fremgangsmåder til behandling af en epilepsilidelse
DK3102673T3 (da) Fremgangsmåder og sammensætninger til behandling af beta-talassæmi
DK3556869T3 (da) Sammensætninger og fremgangsmåder til sekventering af polynukleotider
DK3119797T3 (da) Raav-baserede sammensætninger og fremgangsmåder til behandling af amyotrofisk lateralsklerose
DK3080100T3 (da) Hæmmere af lysinspecifik demethylase-1
DK3594348T3 (da) Kort c/ebp-alpha til aktivering af rna-sammensætninger og anvendelsesfremgangsmåder
DK3007695T3 (da) Sammensætninger og fremgangsmåder til behandling af anæmi
DK3080274T3 (da) Fremgangsmåder og sammensætninger til genom-manipulation
DK2991656T3 (da) Sammensætninger og fremgangsmåder til modulering af apolipoprotein c-iii-ekspression
DK3685848T3 (da) Sammensætninger og fremgangsmåder til behandling af pulmonal hypertension
DK3160956T3 (da) Inhibitorer af lysin-specifik demethylase-1
DK2983787T3 (da) Fremgangsmåde til behandling af posttraumatisk stresssygdom
DK2968208T3 (da) Behandling af kataplexi
DK3511319T3 (da) Hæmmere af lysinspecifik demethylase-1
DK3144001T3 (da) Sammensætninger af selenoorganiske forbindelser og fremgangsmåder til anvendelse deraf
DK3025586T3 (da) Sammensætning til bekæmpelse af plantesygdomme og anvendelse deraf
DK3076976T3 (da) Fremgangsmåder til behandling af cancer
DK3238707T3 (da) Sammensætninger og fremgangsmåder til behandling af intestinal hyperpermeabilitet
DK3363805T3 (da) Fremgangsmåder til syntese af sphingomyeliner og dihydrosphingomyeliner
DK3089707T3 (da) Vævtransplantater og fremgangsmåder til fremstilling og brug af samme
DK3003039T3 (da) Methyl/fluor-pyridinyl-metoxy-substituerede pyridinon-pyridinyl-forbindelser og fluor-pyrimidinyl-metoxy-substituerede pyridinon-pyridinyl-forbindelser
DK3077467T3 (da) Sikkativsammensætning og anvendelse deraf
DK3010895T3 (da) Fremgangsmåde til fremstilling af 4-propargyleret aminobenzoxazinoner
DK3050883T3 (da) Fremgangsmåde til fremstilling af diazabicyclooctanderivater og mellemprodukter